Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Have Conflicting Sentiments on These Consumer Goods Companies: Constellation Brands (STZ), Walmart (WMT) and Colgate-Palmolive (CL)

Tipranks - Thu Apr 16, 6:31AM CDT

Analysts have been eager to weigh in on the Consumer Goods sector with new ratings on Constellation Brands (STZ), Walmart (WMT) and Colgate-Palmolive (CL).

Claim 30% Off TipRanks

Constellation Brands (STZ)

Bank of America Securities analyst Christian Junquera maintained a Sell rating on Constellation Brands today and set a price target of $154.00. The company’s shares closed last Tuesday at $164.50, close to its 52-week low of $160.46.

Constellation Brands has an analyst consensus of Moderate Buy, with a price target consensus of $178.33.

See today’s best-performing stocks on TipRanks >>

Walmart (WMT)

In a report released today, Christopher Nardone from Bank of America Securities maintained a Buy rating on Walmart, with a price target of $150.00. The company’s shares closed last Tuesday at $125.05.

Nardone has an average return of 1.0% when recommending Walmart. ;'>

According to TipRanks.com, Nardone is ranked #1581 out of 12179 analysts.

Currently, the analyst consensus on Walmart is a Strong Buy with an average price target of $138.85, representing a 12.7% upside. In a report issued on April 2, Erste Group also upgraded the stock to Buy.

Colgate-Palmolive (CL)

In a report released today, Filippo Falorni from Citi maintained a Buy rating on Colgate-Palmolive, with a price target of $105.00. The company’s shares closed last Tuesday at $84.16.

According to TipRanks.com, Falorni is a 1-star analyst with an average return of -0.9% and a 53.9% success rate. Falorni covers the Consumer Goods sector, focusing on stocks such as The Estée Lauder Companies, Constellation Brands, and Keurig Dr Pepper. ;'>

Currently, the analyst consensus on Colgate-Palmolive is a Moderate Buy with an average price target of $95.56, implying a 14.7% upside from current levels. In a report issued on April 9, RBC Capital also maintained a Buy rating on the stock with a $102.00 price target.

Read More on STZ:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.